These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Bacterial surface capsular polysaccharides from Streptococcus pneumoniae: A systematic review on structures, syntheses, and glycoconjugate vaccines. Javed ; Mandal PK Carbohydr Res; 2021 Apr; 502():108277. PubMed ID: 33743443 [TBL] [Abstract][Full Text] [Related]
8. Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance. Del Bino L; Østerlid KE; Wu DY; Nonne F; Romano MR; Codée J; Adamo R Chem Rev; 2022 Oct; 122(20):15672-15716. PubMed ID: 35608633 [TBL] [Abstract][Full Text] [Related]
9. American Chemical Society - 229th National Meeting: carbohydrate vaccines. Rotella DP IDrugs; 2005 May; 8(5):387-9. PubMed ID: 15883917 [No Abstract] [Full Text] [Related]
10. Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate Vaccine. Oldrini D; Del Bino L; Arda A; Carboni F; Henriques P; Angiolini F; Quintana JI; Calloni I; Romano MR; Berti F; Jimenez-Barbero J; Margarit I; Adamo R Chemistry; 2020 Jun; 26(31):7018-7025. PubMed ID: 32058627 [TBL] [Abstract][Full Text] [Related]
11. An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity. Khatun F; Stephenson RJ; Toth I Chemistry; 2017 Mar; 23(18):4233-4254. PubMed ID: 28097690 [TBL] [Abstract][Full Text] [Related]
12. A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Ravinder M; Liao KS; Cheng YY; Pawar S; Lin TL; Wang JT; Wu CY J Org Chem; 2020 Dec; 85(24):15964-15997. PubMed ID: 33108196 [No Abstract] [Full Text] [Related]
15. Discovery of Oligosaccharide Antigens for Semi-Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14*. Zhang S; Sella M; Sianturi J; Priegue P; Shen D; Seeberger PH Angew Chem Int Ed Engl; 2021 Jun; 60(26):14679-14692. PubMed ID: 33852172 [TBL] [Abstract][Full Text] [Related]
16. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs. Berti F; Micoli F Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591 [TBL] [Abstract][Full Text] [Related]
17. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease. Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368 [TBL] [Abstract][Full Text] [Related]
18. [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines]. Mulard L Ann Pharm Fr; 2007 Jan; 65(1):14-32. PubMed ID: 17299349 [TBL] [Abstract][Full Text] [Related]
19. Recent mechanistic insights on glycoconjugate vaccines and future perspectives. Berti F; Adamo R ACS Chem Biol; 2013 Aug; 8(8):1653-63. PubMed ID: 23841819 [TBL] [Abstract][Full Text] [Related]
20. NMR assays for carbohydrate-based vaccines. Jones C J Pharm Biomed Anal; 2005 Aug; 38(5):840-50. PubMed ID: 16087046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]